- Filed
- Jan 29, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Jan 15, 2025 | 149.2M sh |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $1.5B |
| Cash And Equivalents | Q3 2025 · Mar 31, 2024 | $1.52B |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $1.29B |
| Current Liabilities | Q3 2025 · Mar 31, 2024 | $1.09B |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $1.63B |
| Total Liabilities | Q3 2025 · Mar 31, 2024 | $1.37B |
| Current Assets | Q3 2025 · Dec 31, 2024 | $2.77B |
| Current Assets | Q3 2025 · Mar 31, 2024 | $2.63B |
| Total Assets | Q3 2025 · Dec 31, 2024 | $3.73B |
| Total Assets | Q3 2025 · Mar 31, 2024 | $3.6B |
| Shares Diluted | Q3 2025 · Dec 31, 2023 | 157.44M sh |
| Shares Diluted | Q3 2025 · Dec 31, 2023 | 158.84M sh |
| Stock Repurchased | Q3 2025 · Dec 31, 2023 | $376.78M |
| Capex | Q3 2025 · Dec 31, 2023 | $45.59M |
| Operating Cash Flow | Q3 2025 · Dec 31, 2023 | $906.01M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $2.19B |
| Stockholders Equity | Q3 2025 · Sep 30, 2023 | $2.08B |
| Stockholders Equity | Q3 2025 · Mar 31, 2023 | $2.26B |
| Eps Diluted | Q3 2025 · Dec 31, 2023 | $1.55 |
| Eps Diluted | Q3 2025 · Dec 31, 2023 | $2.80 |
| Eps Basic | Q3 2025 · Dec 31, 2023 | $1.57 |
| Eps Basic | Q3 2025 · Dec 31, 2023 | $2.82 |
| Sga Expense | Q3 2025 · Dec 31, 2023 | $39.71M |
| Sga Expense | Q3 2025 · Dec 31, 2023 | $116.55M |
| Rd Expense | Q3 2025 · Dec 31, 2023 | $72.7M |
| Rd Expense | Q3 2025 · Dec 31, 2023 | $211.82M |
| Net Income | Q3 2025 · Dec 31, 2023 | $244.68M |
| Net Income | Q3 2025 · Dec 31, 2023 | $444.53M |
| Operating Income | Q3 2025 · Dec 31, 2023 | $222.08M |
| Operating Income | Q3 2025 · Dec 31, 2023 | $457.12M |
| Gross Profit | Q3 2025 · Dec 31, 2023 | $526.78M |
| Gross Profit | Q3 2025 · Dec 31, 2023 | $1.34B |
| Revenue | Q3 2025 · Dec 31, 2023 | $1.26B |
| Revenue | Q3 2025 · Dec 31, 2023 | $3.29B |